Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
28 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/28/3122431/0/en/Alzamend-Neuro-to-Present-at-the-2025-Military-Health-System-Research-Symposium.html
23 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/23/3120190/0/en/Alzamend-Neuro-Reports-Annual-2025-Financial-Results-and-Provides-Update-on-Clinical-Programs.html
16 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/16/3099775/0/en/Alzamend-Neuro-Announces-Final-Closing-of-5-Million-Private-Placement-Months-Ahead-of-Schedule.html
29 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/29/3090267/0/en/Alzamend-Neuro-Announces-Dosing-of-First-Patient-in-its-Phase-II-Clinical-Trial-of-AL001-Lithium-in-Brain-Study-Taking-Place-at-Massachusetts-General-Hospital.html
19 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/19/3083965/0/en/Alzamend-Neuro-Enrolls-First-Patient-in-its-Phase-II-Clinical-Trial-of-AL001-Lithium-in-Brain-Study-Taking-Place-at-Massachusetts-General-Hospital.html
13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3080073/0/en/Alzamend-Neuro-Initiates-First-Phase-II-Clinical-Trial-of-AL001-Lithium-in-Brain-Study-Taking-Place-at-Massachusetts-General-Hospital.html
ABOUT THIS PAGE